Figure 4From: A pilot study of the efficacy of miglitol and sitagliptin for type 2diabetes with a continuous glucose monitoring system and incretin-related markersTime course of CGM measured glucose (A), insulin (B), I/G(insulin to CGM measured glucose ratio) (C), glucagon (D), active GLP-1 (E), and GIP (F) levels before and after meal intake in the patient in case 3.Back to article page